A 42-year-old attorney sits across from me. She hasn't had a drink in nine months, but she can't stop doom-scrolling her phone at 2 a.m., can't stop spending money she doesn't have, can't sit still in a meeting without her leg bouncing like a jackhammer. She tells me her father was an alcoholic. Her brother is in recovery from opioids. And she wants to know: is she broken the same way they are?
The answer, according to the largest genetic study of addiction risk ever conducted, is both more complicated and more reassuring than she expects.
The Study That Changes the Conversation
In March 2026, a team led by Holly Poore at Rutgers Robert Wood Johnson Medical School published a study in Nature Mental Health that analyzed genetic data from more than 2.2 million people. The goal was straightforward: figure out which genes make a person vulnerable to alcohol, tobacco, cannabis, and opioid use disorders. What they found reframes thirty years of addiction genetics.
The bulk of genetic risk for developing a substance use disorder doesn't come from genes tied to any particular drug. It comes from genes that govern how the brain processes rewards, regulates impulses, and weighs consequences. The researchers identified two distinct pathways operating beneath addiction vulnerability. The first, and by far the larger, is a broad “behavioral disinhibition” pathway. This involves brain circuitry for self-control, reward sensitivity, and risk assessment. The second pathway is substance-specific, mapping onto narrower biological functions like alcohol metabolism enzymes or nicotinic acetylcholine receptors that respond to tobacco.
In plainer terms: what most people inherit isn't a vulnerability to vodka or Vicodin. They inherit a brain that runs hotter on reward and softer on the brakes.
Why This Matters More Than Previous Genetic Research
Previous genetic studies tended to examine one substance at a time. You'd see a genome-wide association study for alcohol use disorder, a separate one for opioid dependence, another for nicotine. Each study found its own cluster of genes, and the picture stayed fragmented. What Poore's team did differently was analyze all four substance use disorders simultaneously, alongside related traits like ADHD, conduct problems, and general risk-taking behavior. By modeling addiction together with these externalizing traits, they dramatically increased their ability to detect shared genetic signals without losing the ability to see drug-specific ones.
This matters for patients because it validates something clinicians have observed for decades: the person who struggles with alcohol often also struggles with gambling, impulsive spending, compulsive eating, or risky sexual behavior. We've called this “cross-addiction” or “addiction transfer.” The Rutgers data gives it a genetic address. The same neural architecture that makes one substance dangerous makes many behaviors dangerous, because the underlying vulnerability isn't about the substance. It's about how the prefrontal cortex communicates with the reward system.
I've written before about Reward Deficiency Syndrome, the clinical framework for understanding why some brains chronically underperform in generating natural pleasure. This new research strengthens that framework considerably. The genes driving the behavioral disinhibition pathway are concentrated in brain signaling, reward processing, and neural plasticity. These are the exact circuits that, when underperforming, produce the chronic restlessness and dissatisfaction that drives compulsive behavior.
What the Attorney Actually Inherited
Back to my patient. She didn't inherit “alcoholism genes.” She inherited a brain wiring pattern shaped by hundreds of genetic variants, each one small, collectively powerful, that makes impulse regulation harder and reward-seeking more intense. Her father's drinking was one expression of that wiring. Her brother's opioid use was another. Her late-night phone compulsion and impulsive spending are yet another.
This distinction is not academic. It changes treatment.
If addiction is primarily about a specific drug hijacking a specific receptor, then treatment should focus on blocking that receptor or avoiding that substance. And that's exactly what most rehab programs do: remove the substance, add accountability, hope for the best.
But if the deeper vulnerability is a broadly wired impulse-control deficit, if the brain's reward thermostat is set too low and its braking system too weak, then sobriety from one substance is only the beginning. The brain still needs repair. The circuits still need strengthening. The reward system still needs recalibration.
This is why our Rescue From Rehab program doesn't stop at detox and counseling. We measure the brain. We map the deficits. We use targeted interventions, from IV NAD+ and amino acid therapy to neuromodulation and structured cognitive training, to rebuild the neural infrastructure that addiction has degraded and that genetics may have under-built in the first place.
From Genetic Risk to Genetic Roadmap
The pessimistic reading of this study is that some people are born with stacked odds. The optimistic reading, and the clinically actionable one, is that we now have a clearer map of what needs fixing.
Genes involved in brain signaling and neural plasticity aren't fixed sentences. They're starting conditions. Plasticity, by definition, means the brain can change. The question is whether you have a clinical strategy that targets those specific circuits, or whether you're relying on willpower to do what willpower was never designed to do.
The nutritional foundation matters too. Many of the genes identified in this study regulate neurotransmitter synthesis and receptor sensitivity, processes that depend on adequate precursors, cofactors, and cellular energy. A brain running low on the raw materials for dopamine production can't compensate for a genetic predisposition toward reward deficiency through sheer determination.
When I talk to families about addiction, the most common emotion I encounter is shame. Close behind it is confusion. The shame comes from the cultural myth that addiction reflects character. The confusion comes from watching the same pattern repeat across siblings, parents, and children while being told it's a “choice.” Studies like this one from Rutgers dismantle both. Addiction runs in families because brains run in families. The wiring for impulse control, reward sensitivity, and risk calculation passes from generation to generation through DNA, not through moral failure.
That attorney in my office? She isn't broken the way her father was, or her brother is. She carries the same neural architecture they do, expressing itself through different channels. Understanding that changes what treatment looks like — not just abstinence, but active brain repair, rebuilding the circuits that make triggers so powerful in the first place.
The genetics aren't destiny. But ignoring them is a clinical mistake most treatment programs still make every day.